SutureTech
SutureTech is a surgeon-founded medical device company based in Durham, North Carolina, specializing in the development of innovative internal fixation implants and surgical instruments for soft tissue and tendon repair. The company is dedicated to advancing orthopedic procedures by delivering clinically informed, surgeon-driven solutions that streamline surgical steps, enhance repair strength, and improve patient outcomes. SutureTech's flagship product, RapidFix™, is an all-suture dual anchor system designed for efficient, reliable fixation of soft tissue to bone, and has received FDA 510(k) clearance.
Industries
N/A
Nr. of Employees
small (1-50)
Products
All-suture dual-anchor internal fixation device for tendon-to-bone repair
An all-suture internal fixation implant system designed to secure soft tissue to bone using a horizontal mattress compression repair technique; indicated for a variety of orthopedic soft tissue-to-bone fixation procedures.
All-suture dual-anchor internal fixation device for tendon-to-bone repair
An all-suture internal fixation implant system designed to secure soft tissue to bone using a horizontal mattress compression repair technique; indicated for a variety of orthopedic soft tissue-to-bone fixation procedures.
Expertise Areas
- Tendon and ligament repair device development
- Orthopedic surgical instrumentation
- Biomechanical testing and repair technique optimization
- Preclinical safety and performance validation
Key Technologies
- All-suture internal fixation systems
- Horizontal mattress compression suture technique
- Arthroscopic-compatible implant systems
- Biomechanical testing methods
Key People
CEO/Founder
Lead Engineer
Senior Advisor – Finance & Corporate Development
CEO/Founder
Lead Engineer
Senior Advisor – Finance & Corporate Development
News & Updates
Received FDA 510(k) clearance for the RapidFix™ all-suture dual anchor system, enabling commercialization in the U.S. market.
Selected as one of 64 startups in the MedTech Innovator 2025 Accelerator Cohort, recognizing SutureTech as a high-potential medical technology company.
SutureTech announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for RapidFix™, its flagship all-suture dual anchor system for soft tissue repair.
SutureTech was named one of 64 medtech startups in the 2025 MedTech Innovator Accelerator Cohort, selected from nearly 1,500 global applicants.
SutureTech announced as 2025 MedTech Innovator finalist for the grand prize.
SutureTech is 1 of 5 companies announced as MedTech innovator finalists. This represents just 5 out of approximately 1500 companies that applied to the 2025 MedTech Innovator program. This honor confirms SutureTech as a startup with significant potential to disrupt the market.
Received FDA 510(k) clearance for the RapidFix™ all-suture dual anchor system, enabling commercialization in the U.S. market.
Selected as one of 64 startups in the MedTech Innovator 2025 Accelerator Cohort, recognizing SutureTech as a high-potential medical technology company.
SutureTech announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for RapidFix™, its flagship all-suture dual anchor system for soft tissue repair.
SutureTech was named one of 64 medtech startups in the 2025 MedTech Innovator Accelerator Cohort, selected from nearly 1,500 global applicants.
SutureTech announced as 2025 MedTech Innovator finalist for the grand prize.
SutureTech is 1 of 5 companies announced as MedTech innovator finalists. This represents just 5 out of approximately 1500 companies that applied to the 2025 MedTech Innovator program. This honor confirms SutureTech as a startup with significant potential to disrupt the market.